Thirion Dr. Pierre

"My treatment at James (centre) was excellent with a caring staff who made me feel comfortable.…

read more

Dr. Pierre Thirion


St. Luke's Hospital - see location

St. Luke's Centre at St. James's Hospital - see location

Public Secretary, St. Luke's Hospital 01 406 5000

or St James's Hospital 01 420 6955

  • Lung / GU (prostate -bladder)
  • Thyroid
  • Extracranial Stereotactic Body Radiation therapy

  • IMolecular Biology of Cancer
  • Biological optimization of radiation therapy
  • The development and use of targeted therapeutics and radiation therapy
  • The development of biomarkers of radiation response


The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology.
Eriksen JG, Beavis AW, Coffey MA, Leer JW, Magrini SM, Benstead K, Boelling T, Hj??lm-Eriksson M, Kantor G, Maciejewski B, Mezeckis M, Oliveira A, Thirion P, Vitek P, Olsen DR, Eudaldo T, Enghardt W, Fran??ois P, Garibaldi C, Heijmen B, Josipovic M, Major T, Nikoletopoulos S, Rijnders A, Waligorski M, Wasilewska-Radwanska M, Mullaney L, Boejen A, Vaandering A, Vandevelde G, Verfaillie C, P??tter R. Radiother Oncol. 2012 Apr;103(1):103-8.

Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC).
Walsh L, Gillham C, Dunne M, Fraser I, Hollywood D, Armstrong J, Thirion P.
Radiother Oncol. 2011 Jan; 98(1):38-41.

Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
Thirion P, Holmberg O, Collins CD, O'Shea C, Moriarty M, Pomeroy M, O'Sullivan C, Buckney S, Armstrong J. Radiother Oncol. 2004 May;71(2):163-6.

A randomized trial (Irish clinical oncology research group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer.
Armstrong JG, Gillham CM, Dunne MT, Fitzpatrick DA, Finn MA, Cannon ME, Taylor JC, O'Shea CM, Buckney SJ, Thirion PG.
Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):35-45.

Adjuvant radiotherapy in Stage I endometrial cancer. Where do we stand?
Petnehazi C, Thirion P, Armstrong J.
Eur J Gynaecol Oncol. 2003; 24(6):457-61.

Laparoscopic pelvic sling placement facilitates optimum therapeutic radiotherapy delivery in the management of pelvic malignancy.
Joyce M, Thirion P, Kiernan F, Byrnes C, Kelly P, Keane F, Neary P.
Eur J Surg Oncol. 2009 Apr; 35(4):348-51.

Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer.
Thirion P, Wolmark N, Haddad E, Buyse M, Piedbois P.
Ann Oncol. 1999 Nov; 10(11):1317-20.

A method for the prediction of late organ-at-risk toxicity after radiotherapy of the prostate using equivalent uniform dose.
Fleming C, Kelly C, Thirion P, Fitzpatrick K, Armstrong J.
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):608-13.

A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.
Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P; Meta-analysis Group in Cancer. J Natl Cancer Inst. 2001 Mar 7;93(5):399-401.

Adjuvant chemotherapy of soft tissue sarcoma.
Levy E, Thirion P, Piedbois P.
Cancer Radiother. 1997; 1(5):462-6. Review.

Radiation enteropathy.
Toomey DP, Cahill RA, Geraghty J, Thirion P.
Ir Med J. 2006 Jul-Aug; 99(7): 215-7.

A randomised comparison of two brachytherapy devices for the treatment of uterine cervical carcinoma.
Thirion P, Kelly C, Salib O, Moriarty M, O'Reilly D, Griffin M, Armstrong J.
Radiother Oncol. 2005 Mar; 74(3):247-50.

Factors influencing conformity index in radiotherapy for non-small cell lung cancer.
Brennan SM, Thirion P, Buckney S, Shea CO, Armstrong J. Med Dosim. 2010 Spring; 35(1):38-42.

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
Thirion P, Michiels S, Pignon JP, Buyse M, Braud AC, Carlson RW, O'Connell M, Sargent P, Piedbois P; Meta-Analysis Group in Cancer.
J Clin Oncol. 2004 Sep 15; 22(18): 3766-75. Erratum in: J Clin Oncol. 2005 Feb 20; 23(6):1337-8.

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer.
Thirion P, Piedbois P, Buyse M, O'Dwyer PJ, Cunningham D, Man A, Greco FA, Colucci G, Kohne CH, Di Constanzo F, Piga A, Palmeri S, Dufour P, Cassano A, Pajkos G, Pensel RA, Aykan NF, Marsh J, Seymour MT; Meta-Analysis Group in Cancer. Br J Cancer. 2001 Mar 2; 84(5): 611-20.

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.
Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P.
Lancet. 2000 Jul 29; 356(9227):373-8.

Role of radiotherapy in the treatment of adult nodal non-Hodgkin's lymphoma.
Ganem G, Thirion P. Cancer Radiother. 1999 Mar-Apr; 3(2):129-40.

Preoperative chemoradiotherapy using taxanes for locally advanced esophageal carcinoma.
Thirion P, Piedbois Y.
J Clin Oncol. 2001 Mar 15; 19(6):1880-2.

Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients.
Alapetite C, Thirion P, de la Rochefordiere A, Cosset JM, Moustacchi E.
Int J Cancer. 1999 Sep 24; 83(1): 83-90.

Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.
Cosset JM, Ferme C, Noordijk EM, Dubray BM, Thirion P, Henry-Amar M.
Semin Radiat Oncol. 1996 Jul; 6(3):185-195.